Meet Your Care Team: Karlee Carlin, PA-C
In early May, we welcomed Karlee to our team as a study sub-investigator and clinic care provider. We’re grateful she’s here and are happy…
This research aims to evaluate the safety and effectiveness of a device called ReCET™ for improving blood sugar control in individuals with T2D. The study involves a procedure performed to treat the lining of the first part of the small intestines.
To take part in the study, participants should be:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator